Eterna Therapeutics

#10546

Rank

$5.51M

Marketcap

United States

Country

Leadership team

Dr. Roger Sidhu M.D. (Chief Medical Officer)

Dr. Matthew Angel Ph.D. (CEO & Director)

Mr. Andrew C. Jackson (Chief Financial Officer)

Products/ Services

Biotechnology, Health Care, Medical

Headquarters

San Diego, California, United States

Established

1994

Company Registration

SEC CIK number: 0000748592

Traded as

ERNA

Social Media

URL

https://www.eternatx.com

Overview

Location

Recognition and Award

References

Summary

Eterna Therapeutics Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. The company was formerly known as and changed its name to Eterna Therapeutics Inc. in October 2022. Eterna Therapeutics Inc. is based in Brooklyn, New York.

History

Eterna Therapeutics began as a small biotech with a mission to discover, develop, and commercialize treatments for cancer, immunological, and inflammatory diseases. Founded in 2011, the company has come a long way since its beginnings, rapidly advancing research and progressing its pipeline with the help of strategic collaborations and partnerships worldwide.

Mission

At Eterna Therapeutics, our mission is to provide innovative, meaningful and transformational therapies to address the unmet needs of patients suffering from serious diseases. We take a patient-centric approach when developing our medicines, seeking to understand the patient experience to build better treatments.

Vision

Our vision is to become a leader in the global biologic medicines market, recognized for our unmatched commitment to creating therapeutic solutions for patients with significant unmet medical needs.

Key Team

Dr. Monil Shah M.B.A., Pharm.D. (Chief Operating Officer)

Ms. Sandra M. Gurrola (Principal Accounting Officer & VP of Fin.)

Ms. Lynn Sadowski Mason M.S. (Exec. VP of Clinical Operations)

Ms. Susan McClatchey (VP & Head of Quality)

Recognition and Awards

Eterna has been awarded numerous accolades for its commitment to innovation, scientific advances, and commitment to the patient community. Some of its most recent awards include a Top 10 Award for Most Trusted Biopharmaceutical Companies , a Distinguished Recognition Award for Innovative Leadership , and a Best Place to Work Award .